Skip to main content

Nanoviricides, Inc.

NNVC
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001379006

No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Nanoviricides, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of NNVC: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders3032+2
Shares1.20M1.21M+9.30K (+0.8%)
Value$1.61M$1.24M−$377.3K (−23.4%)

New holders (7)

Institutions that held Nanoviricides, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to NNVC in Q4 2023
InstitutionSharesValue% of portfolio
Citadel Advisors LLC16,821$17.2K0.00%
Virtu Financial LLC16,721$17.0K0.00%
Simplex Trading, LLC2,448$2.00K0.00%
Game Plan Financial Advisors, LLC450$4590.00%
Main Street Group, LTD200$2040.00%
FMR LLC100$1020.00%
Householder Group Estate & Retirement Specialist, LLC150$00.00%

Sold out (5)

Institutions that held Nanoviricides, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of NNVC in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Susquehanna International Group, LLP29,412$39.4K
XTX Topco Ltd10,214$13.7K
Flaharty Asset Management, LLC200$268
Tfo-TDC, LLC65$75
Cary Street Partner Investment Advisory LLC15$20